The Abu Dhabi Investment Authority (ADIA) is expanding its investments in artificial intelligence (AI) by participating in a $200M seed funding round for a U.S. based life sciences company.
A wholly owned ADIA subsidiary made the investment, but the financial details remain undisclosed.
Lila Sciences, backed by Moderna-founded Flagship Pioneering, secured seed funding from Blue Horizon Advisors, an investment firm operating in both the UAE and the UK.
US-based venture capital firms Modi Ventures, March Capital, ARK Venture Fund, and General Catalyst also invested in Lila Sciences.
The funding will help Lila Sciences develop its AI platform, autonomous laboratories, and infrastructure for scaling operations.
Managing nearly $1.1T in assets, ADIA has ramped up its AI investments, including acquiring a $1B stake in US data analytics software firm Qlik last November in a $10B deal.
In January, a wholly owned ADIA subsidiary invested $500M in AlphaGen, a power infrastructure portfolio. The deal is awaiting regulatory approval and should close in the first half of 2025. AlphaGen, one of the largest independent power portfolios in the US, owns over 11 GW of critical power assets, strengthening ADIA’s investments in AI-driven data centres.
LSEG data links ADIA to an investor consortium acquiring a majority stake in Slk Software Pvt Ltd, a Bangalore-based custom software development provider. The group includes ChrysCapital Invest Advisors India Pvt Ltd, Chryscapital Management Co, Hexaware Technologies (a CA Magnum Holdings unit), Altimetrik Corp (a TPG Inc subsidiary), and Mphasis.
Although the financial terms remain undisclosed, reports estimate the deal’s value at 56B Indian rupees ($646M).
